| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067503 Functionalized nanoparticles and methods of use |
| 04/08/2004 | US20040067500 Compositions and methods relating to the peroxisomal proliferator activated receptor-alpha mediated pathway |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067487 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 04/08/2004 | US20040067486 Nucleic acid containing one or more adaptive mutations, and Hepatitis c Virus (HCV) replicon enhanced cells ( cells having an increased ability to maintain an HCV replicon) |
| 04/08/2004 | US20040067483 Compositions, methods and kits for identying protein-protein interaction disrupting agents |
| 04/08/2004 | US20040067242 Multi-subtype FIV vaccines |
| 04/08/2004 | US20040067238 Novel compounds |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067225 Isolated nucleic acid molecules human glucuronyltransferase proteins, and related products and processes |
| 04/08/2004 | US20040067197 Antiproliferative; radioisotope is located internally within a dna sequence; penetrates cell membrane and is retained intracellularly |
| 04/08/2004 | DE19822115B4 Retrovirale Gentransfervektoren Retroviral gene transfer vectors |
| 04/08/2004 | CA2840692A1 Fvii or fviia variants having increased clotting activity |
| 04/08/2004 | CA2540354A1 Nuclear receptor transcriptional corepressor and uses thereof |
| 04/08/2004 | CA2539622A1 Anti-hla assay and methods |
| 04/08/2004 | CA2523618A1 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | CA2500468A1 Influenza therapeutic |
| 04/08/2004 | CA2500397A1 Aav itr-mediated modulation |
| 04/08/2004 | CA2500272A1 A method to diagnose schizophrenia using blood |
| 04/08/2004 | CA2500270A1 Nucleic acid constructs for gene expression |
| 04/08/2004 | CA2500254A1 Method for designing peptides |
| 04/08/2004 | CA2500250A1 Humanized anti-granulocyte mn-3 antibody and uses thereof |
| 04/08/2004 | CA2500224A1 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | CA2499972A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | CA2499880A1 Methods and compositions for modification of splicing of pre-mrna |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499623A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499533A1 Use of excipients to increase dna uptake by swine muscle cells |
| 04/08/2004 | CA2499188A1 Cell-based rna interference and related methods and compositions |
| 04/08/2004 | CA2499042A1 Functional mutations in respiratory syncytial virus |
| 04/08/2004 | CA2498381A1 Acc gene |
| 04/08/2004 | CA2497840A1 Plants transformed with cdc27a, having changed development |
| 04/08/2004 | CA2496913A1 Vector for the production of transplastomic angiosperm plants |
| 04/08/2004 | CA2496761A1 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | CA2485970A1 Methods for diagnosing htlv-i-mediated diseases |
| 04/08/2004 | CA2403025A1 Enzymes with lipase/acyltransferase activity |
| 04/07/2004 | EP1405923A2 Gene mapping method using microsatellite genetic polymorphism markers |
| 04/07/2004 | EP1405922A2 Substrates for beta-lactamase and uses thereof |
| 04/07/2004 | EP1405921A1 Detection of susceptibility to autoimmune diseases, especially type 1 diabetes |
| 04/07/2004 | EP1405916A1 Recombinant vaccinia virus incapable of expressing the A41L gene |
| 04/07/2004 | EP1405915A1 IL-4 trap based on IL receptor fusion proteins |
| 04/07/2004 | EP1405914A1 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from flavobacterium heparinum |
| 04/07/2004 | EP1405913A2 Process for improving the production of 5R clavams |
| 04/07/2004 | EP1405912A1 Genetically modified ecarin and process for producing the same |
| 04/07/2004 | EP1405911A1 Interaction trap systems for detecting protein interactions |
| 04/07/2004 | EP1405908A1 Creation of high yield heterologous expression cell lines |
| 04/07/2004 | EP1405863A1 Concentrate of a factor VIII:C-containing von-Willebrand-factor and a process for producing it |
| 04/07/2004 | EP1405668A1 Novel separation agent for separating optical isomer and method for preparation thereof |
| 04/07/2004 | EP1405666A2 Substrate for methods to determine analytes and methods to manufacture such substrates |
| 04/07/2004 | EP1405560A1 Il-18 transgenic animal |
| 04/07/2004 | EP1405558A1 Method of elevating glutamic acid content in plant and plants having elevated glutamic acid content |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405082A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 04/07/2004 | EP1405074A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1405070A2 Selection of target sites for antisense attack of rna |
| 04/07/2004 | EP1405068A1 Methods for cloning mammals using remodeling factors |
| 04/07/2004 | EP1404880A2 Method for identifying nucleic acid molecules amplified in a polymerase chain reaction |
| 04/07/2004 | EP1404878A1 Internal calibration standards for electrophoretic analyses |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404872A2 Method of selecting a dna sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity |
| 04/07/2004 | EP1404870A2 Function and application of tob gene in central nervous system of mammal |
| 04/07/2004 | EP1404868A2 Compositions and methods relating to osteoarthritis |
| 04/07/2004 | EP1404867A2 Oligonucleotide transfection screening method |
| 04/07/2004 | EP1404866A1 Bioassay for myostatin |
| 04/07/2004 | EP1404865A2 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 04/07/2004 | EP1404864A2 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 04/07/2004 | EP1404863A1 PIBs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404862A1 Thermostable proteinases from thermophilic bacteria |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404859A2 Proteins that regulate systemic acquired resistance in plants |
| 04/07/2004 | EP1404858A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404857A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404856A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404852A1 Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter |
| 04/07/2004 | EP1404851A2 Production of proteins in plants |
| 04/07/2004 | EP1404850A2 Methods for enhancing segregation of transgenes in plants and compositions thereof |
| 04/07/2004 | EP1404849A2 Modification of plant genomes by inducible site-specific recombination of transgenes |
| 04/07/2004 | EP1404848A2 Gene expression in plastids based on replicating vectors |
| 04/07/2004 | EP1404847A2 Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene |
| 04/07/2004 | EP1404846A1 Method for obtaining cells with new properties |
| 04/07/2004 | EP1404845A2 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 04/07/2004 | EP1404844A2 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 04/07/2004 | EP1404843A2 Regulation of human nek-like serine/threonine protein kinase |
| 04/07/2004 | EP1404842A2 Perv screening method and use thereof |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404839A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404838A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression |
| 04/07/2004 | EP1404837A2 Process for the preparation of l-amino acids using strains of the enterobacterialceae family with enhanced pts-g expression |
| 04/07/2004 | EP1404836A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 04/07/2004 | EP1404835A2 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced mop-b expression |
| 04/07/2004 | EP1404834A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/07/2004 | EP1404833A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/07/2004 | EP1404832A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404830A2 Method of preparing polynucleotide fragments for use in shuffling |
| 04/07/2004 | EP1404829A1 Novel aminopeptidase derived from bacillus licheniformis, gene encoding the aminopeptidase, expression vector containing the gene, transformant and method for preparation thereof |